Koshinski Asset Management Inc. Acquires 479 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Koshinski Asset Management Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 14,094 shares of the healthcare conglomerate’s stock after buying an additional 479 shares during the quarter. UnitedHealth Group comprises approximately 0.7% of Koshinski Asset Management Inc.’s investment portfolio, making the stock its 21st largest holding. Koshinski Asset Management Inc.’s holdings in UnitedHealth Group were worth $7,239,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock worth $41,119,347,000 after purchasing an additional 1,147,051 shares in the last quarter. State Street Corp increased its position in shares of UnitedHealth Group by 1.6% during the first quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock worth $23,598,745,000 after acquiring an additional 714,903 shares in the last quarter. Capital World Investors boosted its stake in UnitedHealth Group by 2.8% during the 1st quarter. Capital World Investors now owns 34,805,861 shares of the healthcare conglomerate’s stock valued at $17,750,351,000 after purchasing an additional 935,552 shares during the last quarter. Capital International Investors lifted its holdings in shares of UnitedHealth Group by 4.3% in the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock valued at $9,713,058,000 after purchasing an additional 790,219 shares in the last quarter. Finally, Capital Research Global Investors raised its position in UnitedHealth Group by 8.3% in the 1st quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after buying an additional 1,482,338 shares during the last quarter. 87.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Mizuho raised their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Loop Capital assumed coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target on the stock. SVB Leerink lifted their target price on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price on the stock. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Finally, Morgan Stanley upped their price objective on UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $585.65.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at $18,866,882.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. In the last ninety days, insiders sold 139,051 shares of company stock worth $74,450,958. 0.40% of the stock is currently owned by insiders.

UnitedHealth Group Trading Down 2.1 %

Shares of UNH stock opened at $512.08 on Thursday. The company has a market capitalization of $478.99 billion, a PE ratio of 26.74, a price-to-earnings-growth ratio of 1.64 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. The business’s fifty day moving average is $529.81 and its 200 day moving average is $512.24. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. UnitedHealth Group’s revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period in the prior year, the business earned $4.70 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s payout ratio is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.